Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Feb 24 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 9.18 | 17,700 | 162.49 k | 17,700 |
3 Jan 24 | ONCT Oncternal Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 0.4961 | 11,838 | 5.87 k | 44,019 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.31 | 220,000 | 68.20 k | 220,000 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.31 | 28,750 | 8.91 k | 28,750 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.31 | 177,050 | 54.89 k | 177,050 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.31 | 160,000 | 49.60 k | 160,000 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.31 | 12,470 | 3.87 k | 12,470 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.31 | 40,000 | 12.40 k | 40,000 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.31 | 75,000 | 23.25 k | 75,000 |
2 Oct 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.96 | 220,000 | 211.20 k | 0 |